Global Portable Medical and Healthcare Devices Market Expected to Grow at a CAGR of 17% During 2017-2022

The global portable medical and healthcare devices market has recorded a CAGR of 18% during 2009-2016. The active government involvement, aging population, technological advancements, etc. are further expected to influence the market and contribute to the growth.

Request sample report @ http://www.imarcgroup.com/request?type=report&id=704&flag=B

According to the latest report by IMARC Group titled, ‘‘Global Portable Medical and Healthcare Devices Market Report (Cardiac Monitoring Devices, Blood Glucose Monitoring, Pulse Oximetry Devices, Wearable BP Monitors, Smart Wrist-Wearables, Smart Garments etc.) (2017-2021)’’, the global portable medical and healthcare devices market has grown at a CAGR of 18% during 2009-2016, reaching a value of around US$ 35 Billion in 2016. A tremendous increase in the lifestyle diseases caused by dramatic changes in the patterns of living, such as excessive smoking, binge drinking, sedentary lifestyle, etc., is one of the major concerns in the current century. All this has led to a sudden growth in cardiovascular diseases, stroke, obesity and type 2 diabetes among a vast majority of the population. The treatment of such diseases requires expert medication and constant monitoring to keep health and fitness in check. Following this demand, the market for portable medical and healthcare devices is growing at a sizeable rate facilitated by the emergence of smart technology and wireless capabilities. This has enabled the people to diagnose and chart the progress of their treatment without paying frequent visits to the doctor.

Highlights of the global portable medical and healthcare devices market:

  • The market growth is encouraged by government initiatives and programmes.
  • The market is segmented into medical monitoring devices and wearable health and fitness devices.
  • The United States represents the largest market for global portable medical and healthcare devices.

The major factor which have thrust impetus to the market growth is the rise in government initiatives and programmes to help create an awareness about various diseases and their treatments. It is a major step toward preventing the dissemination of the curable diseases which go unnoticed and untreated due to lack of awareness. Apart from this, an increasing portion of ageing population is also creating a demand of such devices. Portable medical and healthcare devices not only provide convenience of use to their users, they are also cost-effective. Owing to these factors, the market is further expected to grow at a CAGR of 17% during 2017-2022, reaching a value of more than US$ 86 Billion by 2022.

The market for portable medical and healthcare devices is segmented as medical monitoring devices and wearable health and fitness devices. The medical monitoring devices segment is further multifurcated into vital signs monitoring devices, foetal monitoring devices, neuromonitoring devices, blood glucose monitoring devices, anaesthesia monitoring devices. The wearable health and fitness devices include smart wrist-wearables, smart garments and chest straps.

On the basis of geographical analysis, the United States represents the largest market for global portable medical and healthcare devices, accounting for more than one-third of the total share. The United States is followed by Europe and Asia-Pacific. Considering the changes in the market trends, the market share of Asia-Pacific is expected to increase in the next few years due to upcoming opportunities and rising disposable incomes, especially in India and China. Some of the key players operative in the market include Philips Healthcare, GE Healthcare, Abbott Laboratories, Fitbit Inc., Garmin and Medtronic.

Read full report with TOC @ http://www.imarcgroup.com/global-portable-health-monitoring-devices-market

The report by IMARC Group has examined the global portable medical and healthcare devices market on the basis of:

Types:

  • Medical Monitoring Devices
  • Wearable Health and Fitness Devices

Regions

  • United States
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • China
  • Japan
  • Brazil

Key players:

  • Philips Healthcare
  • GE Healthcare
  • Abbott Laboratories
  • Fitbit Inc.
  • Garmin
  • Medtronic

Find more reports on healthcare industry @ http://www.imarcgroup.com/categories/healthcare-market-research-reports

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact us

IMARC Group
309 2nd St, Brooklyn, NY 11215, USA
Website: www.imarcgroup.com
Email: sales@imarcgroup.com
USA: +1-631-791-1145
Follow us on twitter: @imarcglobal

Advertisements

Global Biopharmaceutical Manufacturing Market: Share, Size and Forecast 2017-2022

The global biopharmaceutical manufacturing industry has witnessed a balanced growth over the past several years, owing to the increasing popularity of biopharmaceuticals along with capacity expansions, advancements in technology and the emerging trend of outsourcing activities.

The latest report by IMARC Group titled, “Global Biopharmaceutical Manufacturing Market Report 2017-2021”, finds that the global biopharmaceutical manufacturing capacity has grown at a CAGR of more than 4% during 2009-2016, reaching a volume of around 4.5 Million Litres in 2016. Biopharmaceuticals currently represent the fastest growing segment in the global pharmaceuticals market on account of their various health benefits. The high returns associated with their production has also prompted a number of companies to develop and manufacture biopharmaceutical drugs. Moreover, the emergence of biosimilars coupled with capacity expansions are further expected to bolster the market growth. According to the report, the global biopharmaceutical manufacturing market is projected to reach a volume of 6.6 Million Litres by 2021.

Biopharmaceutical Manufacturing

Request sample of the report: http://www.imarcgroup.com/request?type=report&id=724&flag=B

Highlights of the Global Biopharmaceutical Manufacturing Market:

  • Continuous improvements in technology and growth in outsourcing activities remain the major drivers.
  • Mammalian cell culture represents the largest category, accounting for the majority of production volume.
  • North America dominates the market, accounting for nearly half of the market share.

One of the major trends in the market is the continuous improvement in technology aimed at increasing productivity. Manufacturers are focusing on processes such as continuous bioprocessing and the use of single-use or disposable devices so as to increase the yield. Moreover, owing to the significant cost savings and effectiveness as well as innovation and specific capabilities offered by the contract manufacturers, a number of companies are outsourcing various production activities to them. The contract manufacturers carry out activities ranging from the analytical testing of bioassays to testing the cell line stability and product characterisation. A large number of contract manufacturers are based in emerging regions such China and India which are progressively becoming a major destination for outsourcing.

To get more infromation, please visit @ http://www.imarcgroup.com/global-biopharmaceutical-manufacturing-market

On the basis of the cell culture, the market has been divided into mammalian and microbial cell cultures. Mammalian cell culture currently represents the largest category, accounting for the majority of the production volume. This can be attributed to the large number of drugs which are made using mammalian cell cultivation. On the basis of class, the market has been segmented into recombinant proteins, monoclonal antibodies, interferons, erythropoietin, granulocyte colony-stimulating factor (G-CSF), recombinant human insulin, vaccines and human growth hormones (HGH). On the basis of region, North America currently represents the largest market, accounting for nearly half of the total market share. Some of the key players operating in the market include Biogen Idec, Roche, Eli Lilly, Amgen, Merck & Co., Novo Nordisk, Pfizer, AbbVie, Sanofi S.A and Johnson & Johnson.

The report by IMARC Group has examined the global biopharmaceutical manufacturing market on the basis of:

Cell Culture:

  • Mammalian Cell Culture
  • Microbial Cell Culture

Class:

  • Monoclonal Antibodies
  • Recombinant Proteins
  • Interferon
  • Granulocyte Colony-Stimulating Factor (G-CSF)
  • Erythropoietin
  • Recombinant Human Insulin
  • Vaccines
  • Human Growth Hormones

Region:

  • North America
  • Europe
  • Asia

Major Manufacturers:

  • Roche
  • Amgen
  • Novo Nordisk
  • AbbVie
  • Sanofi SA
  • Johnson & Johnson
  • Pfizer
  • Merck & Co.
  • Ely Lilly
  • Biogen Idec

Browse more related reports:

Generic Pharmaceutical Market – Industry Trends, Manufacturing Process, Plant Setup, Machinery, Raw Materials, Cost and Revenue

Generic Drugs Market: Global Industry Trends, Manufacturing Process, Share, Size, Growth, Opportunity and Forecast 2017-2022

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group
Tel No: +1-631-791-1145
Email: sales@imarcgroup.com
Website: http://www.imarcgroup.com
Follow us on twitter: @imarcglobal

Anti-Aging Market: Share, Size and Forecast 2017-2022

The global anti-aging market has witnessed positive growth owing to advancements in technology along with a steady rise in aging population and increasing disposable income of consumers. The market is further expected to grow at a CAGR of 8% during 2017-2021.

IMARC Group’s new report, titled “Global Anti-Aging Market Report and Forecast (2017-2022)”, finds that the global anti-aging market reached a value of US $ 43.66 Billion in 2016, growing at a CAGR of 7.2% during 2009-2016. With increasing focus on physical appearance, both young and old consumers are seeking out anti-aging and preventive skin and hair care solutions. This trend coupled with the rising consumer base for quick and effective anti-aging solutions has boosted the demand for anti-aging products. As a result, various firms are making large investments in research and development of innovative technology, and in manufacture of diverse anti-aging products. According to the report, the global anti-aging market is expected to reach a value of 63.48 Billion by 2021, growing at a CAGR of around 8% during 2017-2021.

Request sample of the report: http://www.imarcgroup.com/request?type=report&id=672&flag=B

Anti-Aging Market.jpg

Highlights of the Global Anti-Aging Market:

  • Technological advancement and steady growth in aging population are driving the anti-aging market.
  • People belonging to the high-income group account for the majority of consumption.
  • Skin-care industry represents the largest industry, accounting for almost three-fourths of the global output.

One of the major factors driving the global anti-aging market is the rising population of people above the age of 35 years. People belonging to this age group account for a significant part of the total population and contribute to the rising demand for these products. Owing to the technological advancements, and introduction of safer and effective anti-aging cosmetics in the market, the consumer base of these products has expanded. Nowadays, middle class consumers are also going for premium personal care products due to an increase in disposable incomes. Brand and product endorsements by celebrities have also played a crucial role in influencing consumers and establishing the anti-aging industry.

To get more infromation, please visit @ http://www.imarcgroup.com/anti-aging-market

The anti-aging market has been segmented on the basis of key demographic factors like age, gender and income group. People belonging to the age group of 35-55 year account for about half of the total consumption. Moreover, this market is dominated by females and people belonging to high-income group. On the basis of industry, the skin care industry accounts for about three-fourths of the global production, followed by the hair care and dental care industries. The market has been further segmented on the basis of key product categories, and key devices and technology. On the basis of region, the US accounts for the majority of the global anti-aging market, followed by Japan, France, Brazil, Germany, China, South Korea and Italy. Some of the major players operating in this market include Allergan, L’Oréal, Beiersdorf, Estee Lauder, Procter & Gamble, Shiseido and Unilever.

The report by IMARC Group has examined the Global Anti-Aging Market on the basis of:

Demography:

  • Age group
  • Gender
  • Income

Industry:

  • Skin care
  • Hair care
  • Dental care

Key product categories:

  • Anti-wrinkle creams
  • Botulinum Toxin A Injections
  • Dermal fillers
  • Anti-pigmentation products
  • Chemical peels
  • Sunscreen products
  • Hair care products

Key devices and technology:

  • Microdermabrasion devices
  • Aesthetic energy devices
  • Radio frequency devices
  • Ultrasound devices

Region:

  • France
  • Germany
  • Italy
  • United Kingdom
  • Russia
  • Spain
  • United states
  • Brazil
  • Japan
  • South korea
  • China
  • Thailand
  • India

Key players:

  • Allergan
  • L’Oréal
  • Beiersdorf
  • Estee Lauder
  • Procter & Gamble
  • Shiseido
  • Unilever

 

Browse more related reports:

Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

Global Biopharmaceutical Manufacturing Market Report 2017-2021

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group
Tel No: +1-631-791-1145
Email: sales@imarcgroup.com
Website: http://www.imarcgroup.com
Follow us on twitter: @imarcglobal

Global Aloe Vera Gel Market Share, Size , Price Trends and Forecast 2017-2022

The global Aloe Vera gel market has experienced tremendous growth in the past few years, growing at a CAGR of 9% during 2009-2016. The primary factor driving the growth is its healing medicinal properties which render it valuable for a number of industries such as healthcare, cosmetics and food & beverages.

A recently published report by IMARC Group titled “Aloe Vera Gel Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, finds that the global Aloe Vera gel market has grown at CAGR of around 9% during 2009-2016, reaching a value of US$ 465 Million in 2016. Aloe Vera belongs to the liliacea family and has thick green leaves which contain latex and gel. The gel, which is a colourless and transparent liquid, consists mainly of water. The rest contains several amino acids, enzymes, vitamins, hormones, minerals and sugars; most of which are found in the human body. The demand of Aloe Vera gel in the consumer market is driven by its healing and restorative properties, due to which it finds applications in several industries. Apart from this, the other factors contributing to the market growth include scientific research on the health benefits of Aloe Vera based products, rising disposable incomes, supplier innovations. According to the report the market is further expected to reach values of US$ 769 Million by 2022.

Request sample of the report: http://www.imarcgroup.com/request?type=report&id=634&flag=B

Owing to its therapeutic properties, Aloe Vera gel is used in a variety of industries such as pharmaceuticals, cosmetics and food & beverages. In the healthcare industry, Aloe Vera gel is used in various products such as tonics, tablets, capsules, salves and supplements. It helps in treating wounds and various skin ailments. It has also been proven effective in treating psoriasis, lowing LDL and sugar levels and increasing HDL. In the cosmetic industry, Aloe Vera gel finds several applications in organic and herbal products. Some of the products where Aloe Vera gel is used as an essential ingredient include hair masks, hair tonics, eyeliners, sun blocks, shampoos, conditioners, etc. Additionally, as a result of increasing health consciousness among the consumers, manufacturers in the food & beverage industry are introducing products containing Aloe Vera gel such as tea, juices, instant drink powders, flavoured drinks, etc.

To get more infromation, please visit @ http://www.imarcgroup.com/aloe-vera-gel-manufacturing-plant

The report has conducted a thorough evaluation of the market on the basis of regions. Some of the key regions included in the report are Thailand, Dominican Republic, United States, Mexico and Costa Rica. Amongst these, Thailand represents the largest producer of Aloe Vera gel accounting for more than a third of the total global production. Asia, on the other hand, represents the largest consumer of Aloe Vera gel accounting for the majority of the total global consumption. The report has also analysed the competitive landscape of the market. Some of the key players covered in the report are Herbalife International, Aloecorp, Aloe laboratories, Forever Living Products and Aloe Vera Australia.

The report gives a detailed roadmap for starting an Aloe Vera gel manufacturing plant. The study, done by one of the leading research and advisory firms, covers all the requisite aspects of the global Aloe Vera gel market. This ranges from a comprehensive view of the market to minute details of the industry performance, processing & manufacturing requirements, project cost, project funding, project economics, expected returns on investment, profit margins, etc. It also offers SWOT, Value Chain and Porter’s Five Forces analysis and regional segmentation followed by an analysis of the competitive landscape. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who are planning to foray into the Aloe Vera gel market in any manner.

Browse more related reports:

Ginger Processing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

Ghee Market in India: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2021

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group
Tel No: +1-631-791-1145
Email: sales@imarcgroup.com
Website: http://www.imarcgroup.com
Follow us on twitter: @imarcglobal

Global Nutraceuticals Market – Size, Growth, Trends, Industry Analysis And Outlook 2017 – 2022

The global nutraceuticals market has witnessed significant growth over the past several years. This can be attributed to several factors such as new product launches, growing health consciousness among consumers, increasing disposable incomes, prevalence of lifestyle diseases, etc.

Nutraceuticals

Request for sample report @www.imarcgroup.com/request?type=report&id=538&flag=B

The new report published by IMARC Group titled, “Nutraceuticals Market Report: COQ10, Probiotics/Prebiotics, Taurine, Omega-3, Green Tea, Antioxidants, Calcium, Lycopene, B-Complex, Dietary Fibre, Collagen, Aloe Vera and Zinc”, finds that the global nutraceuticals market reached a value of more than US$ 230 Billion in 2016, exhibiting a CAGR of 5% during 2009-2016. Nutraceuticals are food and beverages which cater to individual nutritional demands and offer health benefits beyond basic nutrition. Nutraceuticals range from fortified products (such as vitamin-fortified juices) to enhanced commodities(such as eggs with higher omega-3 content). These products can be required due to certain health conditions, professional needs or food allergies and intolerances, and can help enhance immunity and digestion, prevent chronic diseases, improve cognitive behaviour, etc.

Highlights of the Global Nutraceuticals Market:

  • The shifting consumer preference towards personalised nutrition products remains the major growth driver.
  • Digestive and immune health products dominated the market, representing the most popular indication type.
  • The United States is the largest market, accounting for around a fourth of the global share.

The market is currently being driven by a number of growth inducing factors. One of the major factors is the shift towards personalized nutrition which has enabled the manufacturers to provide products that are better suited to the individual health and nutritional requirements of the consumers. Furthermore, the increase in the aging population and the prevalence of lifestyle diseases, particularly in the developed regions, has encouraged the demand for nutraceuticals. Several other factors such asbetter understanding towards fitness, growing health concerns, lifestyle changes,increasing disposable incomes and demand from emerging regions are alsostimulating the global nutraceutical market. New product launches are further projected to strengthen the market growth.Owing to these factors, the market is expected to reach a value of US$ 350 Billion by 2022.

The global nutraceuticals market is segmented as personalised foods and personalised beverages. As these personalised products eithertarget theconsumers’ medical conditionsor addressindividual health requirements, the market is sub-divided into key indicative health areas. These include digestive and immune health,heart health, energy and alertness health, cognitive health, bone and joint health and beauty health. Products for digestive and immune health currently account for the majority of the total global sales.

On the basis of region, the United States represents the largest market for nutraceuticals accounting for more than a fourth of the total global share. The other major regions include the United Kingdom, Brazil, Japan, Mexico and China. The market is fragmented in nature owing to the presence of a number of players. Currently, PepsiCo represents the largest functional food company in the world with brands such as Quaker cereals, Tropicana and Dole juices, SoBE non-carbonated energy drinksand Gatorade.Some of the other key players include Coca Cola, Otsuka, Yakult Honsha, Danone, GlaxoSmithKline, Cadbury, Morinaga, Nestlé and Kirin Brewery.

Read full report with TOC @ www.imarcgroup.com/global-nutraceuticals-market

The report has examined the global nutraceuticals market on the basis of:

Type:

  • Personalised Foods
  • Personalised Beverages

Region:

  • United States
  • China
  • Mexico
  • Japan
  • Brazil
  • United Kingdom

Major Manufacturers:

  • PepsiCo Inc.
  • Coca Cola
  • Otsuka
  • Yakult Honsha
  • Danone
  • GlaxoSmithKline
  • Cadbury
  • Morinaga
  • Nestlé
  • Kirin Brewery

Browse more reports on healthcare industry @ http://www.imarcgroup.com/categories/healthcare-market-research-reports

About IMARC Group

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact us

IMARC Group

309 2nd St, Brooklyn, NY 11215, USA
Website: www.imarcgroup.com
Email: sales@imarcgroup.com
USA: +1-631-791-1145
Follow us on twitter: @imarcglobal

Canada Generic Drug Market – Share, Size, Growth, Trends, Industry Analysis And Outlook 2017 – 2022

The Canada generic drug market has witnessed a significant growth over the past several years, reaching a volume of around 0.46 Billion Units in 2016. This can be attributed to public and private sector drugs programs and healthcare initiatives promoting the use of generic drugs.

Canada currently represents the ninth-largest generic drug market worldwide, accounting for nearly 3% of the total global share. The share of generic drugs in the pharmaceuticals market has increased significantly over the past several years. At present, generic drugs account for around 70% of the total retail prescriptions, and 22% of the total pharmaceutical sales value in the region. This can be attributed to the various public and private sector drug programs aimed at cost-containment and increasing awareness about generic drugs. The latest report by IMARC Group titled, “Canada Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, finds that the Canada generic drug market reached a volume of around 0.46 Billion Units in 2016, growing at a CAGR of around 8% during 2010-2016.

Get Sample of the Report: http://www.imarcgroup.com/request?type=report&id=700&flag=B

Highlights of the Canada Generic Drug Market:

Generic drugs account for nearly 70% of the total retail prescriptions in Canada.
Changing demographics and government initiatives are the major growth drivers.
Patent expiry of a number of blockbuster drugs is expected to provide growth opportunities.

Population growth, changing demographics, increasing prevalence of chronic diseases and a rise in the use of drug therapy are projected to put more pressure on Government healthcare initiatives such as the ‘drug benefit plans’ operative in the Canadian territories and provinces. As the sustainability of these programmes is largely dependent on the use of generic drugs, the demand for these drugs is expected to increase over the next several years. Moreover, the patent expiry of a number of blockbuster drugs is also anticipated to expand the generic drug market in Canada. According to the report, the market is further expected to reach a volume of nearly 0.7 Billion Units by 2022.

Browse full report with TOC @ http://www.imarcgroup.com/canada-generic-drug-market

The report analyses the competitive landscape of the market and provides details of the major players in the market. Some of these include Teva Pharmaceutical Ltd., Apotex Inc., Snadoz Canada, Actavis, Mylan, Pharmascience Inc., Taro Pharmaceuticals, Novartis, Ranbaxy Pharmaceuticals Canada and Hospira. The report provides a comprehensive insight into the historical and current trends as well as the future prospects of the generic drug market in Canada. This study serves as an exceptional tool to understand the sales trends, volume trends, growth, key segments, competitive structure, regulations, major manufacturer, major distributors, top drugs, manufacturing requirements, opportunities and future prospects of the Canada generic drug market. This report can serve as an excellent guide for manufacturers, consultants, researchers, marketing strategists and all those who plan to foray into the Canada generic drug market in any form.

Find more reports on healthcare industry @ http://www.imarcgroup.com/categories/healthcare-market-research-reports

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group
USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: http://www.imarcgroup.com
Follow us on twitter: @imarcglobal

Global Biopharmaceutical Market to Grow at 8% During 2016-2021 With Manufacturers Turning to Untapped Regions

Image result for biopharmaceutical

In order to expand and diversify their operations outside their core markets, biopharmaceutical giants are trying to penetrate emerging markets by collaborating with local pharmaceutical companies or setting up their manufacturing facilities in these regions.

IMARC’s latest report Global Biopharmaceutical Market Report & Forecast (2016-2021)” provides an in-depth analysis of the global biopharmaceutical market along with a comprehensive study of market trends, geographical structure, therapeutic structure, competitive structure and market outlook. Biopharmaceuticals are large, complex molecules extracted from biological sources such as yeast, E. coli and mammalian cell cultures. Currently, the applications of biopharmaceuticals are increasing as they have high efficiency, limited generic threat, are target oriented and can be used to treat ailments such as cancers and autoimmune diseases. Biopharmaceuticals also have a higher approval rate compared to small molecule drugs and have a very strong tendency to achieve blockbuster status. According to the report, the global biopharmaceutical market was valued at nearly US$ 160 Billion in 2015, growing at a CAGR of 9% during 2008-2015.  The market is expected to grow a CAGR of nearly 8% during 2016-2021 as a result of the rising prevalence of chronic diseases such as diabetes, autoimmune diseases, cancers etc., an ageing global population and a significant number of monoclonal antibodies in the pipeline.

Browse full report at: http://www.imarcgroup.com/biotechnology-industry

The report has segmented the market on the basis of key regions. As a result of scientific advancements and research facilities, the biopharmaceutical market is largely concentrated in the United States and Western Europe with the United States representing the world’s largest biopharmaceutical market. However, the growth rates in these markets are expected to decline as both the government and private insurance providers are likely to apply cost containment measures. Consequently, biopharmaceutical giants are focussing on emerging markets such as China, Brazil, India, Russia, Turkey, South Korea and Mexico in order to expand their business. The huge population of these regions along with rising incomes, expanding health insurance coverage and increasing demand for top-shelf medical treatments is expected to drive the global biopharmaceutical market in these regions.

The report has further segmented this market on the basis of various biopharmaceutical classes. Recombinant proteins currently represent the biggest segment of the biopharmaceutical market accounting for the majority of the global sales. Recombinant proteins were followed by monoclonal antibodies and purified proteins. Monoclonal antibodies, on the other hand, are expected to be the fastest growing class. The report has further analysed the competitive landscape of this market. Some of the key players included in the report are – Roche, Amgen, Novo Nordisk, AbbVie, Sanofi, Johnson & Johnson, etc.

Enquiry for sample report or more details, click here: http://www.imarcgroup.com/enquiry-form/

 

Contact Us

IMARC Group
Tel: +91-120-415-5099
USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: http://www.imarcgroup.com
Follow us on twitter: @imarcglobal